LyphoMed Inc intend file registration statement Securities Exchange Commission cover sale 70 mln dlrs principal amount convertible subordinate debentures. Concurrent debenture offering LyphoMed plan sell additional 30 mln dlrs debenture Fujisawa Pharmaceutical Co Ltd currently own 30 pct company's common stock. It offering prospectus. Reuter 